Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHARLES F LOVELL

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1174629448
CMS profile
325880
Location
NORFOLK, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$2,823.11

39 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,168.00 2
Food and Beverage $586.93 35
Education $56.45 1
Travel and Lodging $11.73 1

By paying entity

PY2020 · entire year · sorted by reported total

Page 1 of 1; records 1–39 of 39 matching records. This page contains 39 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHARLES F LOVELL

NPI 1174629448 · CMS profile ID 325880

Allopathic & Osteopathic Physicians / Internal Medicine

NORFOLK, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–39 of 39 matching records. This page contains 39 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1174629448?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHARLES F LOVELL, NPI 1174629448, CMS profile ID 325880. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–39 of 39 matching records. This page contains 39 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1174629448?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). CHARLES F LOVELL, NPI 1174629448, CMS profile ID 325880. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–39 of 39 matching records. This page contains 39 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1174629448?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
CHARLES F LOVELL, NPI 1174629448, CMS profile ID 325880, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–39 of 39 matching records. This page contains 39 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1174629448?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

39 matching records · $2,823.11 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 39 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–39 of 39.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $8.8012/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736085981 CMS
Lilly USA, LLC $11.6711/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728399275 CMS
Amarin Pharma Inc. $13.5010/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739832297 CMS
AstraZeneca Pharmaceuticals LP $21.8910/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736025485 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.2909/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720919095 CMS
Relypsa, Inc. $20.0309/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 742183261 CMS
Arbor Pharmaceuticals, Inc. $11.0708/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735730701 CMS
Amarin Pharma Inc. $14.2408/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739827857 CMS
AstraZeneca Pharmaceuticals LP $22.8408/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735918897 CMS
Allergan, Inc. $17.4907/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723425119 CMS
Amarin Pharma Inc. $14.4507/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739832383 CMS
Strongbridge US INC. $13.2707/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735174719 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.2307/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720919101 CMS
Novartis Pharmaceuticals Corporation $17.6906/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725995793 CMS
Strongbridge US INC. $16.8006/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735174421 CMS
Janssen Pharmaceuticals, Inc $14.7006/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719075193 CMS
AstraZeneca Pharmaceuticals LP $512.0006/16/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736070423 CMS
AstraZeneca Pharmaceuticals LP $15.0406/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736078361 CMS
Amarin Pharma Inc. $14.5605/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739827849 CMS
AstraZeneca Pharmaceuticals LP $19.3705/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736106001 CMS
Amarin Pharma Inc. $14.5504/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739827853 CMS
Janssen Pharmaceuticals, Inc $13.6004/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719075195 CMS
Hikma Pharmaceuticals USA $13.8204/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 729269397 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $11.8404/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720919105 CMS
AstraZeneca Pharmaceuticals LP $21.1003/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735843081 CMS
Corcept Therapeutics $15.2503/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744739189 CMS
Amarin Pharma Inc. $19.4203/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739839785 CMS
Kowa Pharmaceuticals America, Inc. $11.7303/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 716758575 CMS
E.R. Squibb & Sons, L.L.C. $20.2603/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727981161 CMS
E.R. Squibb & Sons, L.L.C. $11.7303/11/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727981165 CMS
Novartis Pharmaceuticals Corporation $19.6803/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725995791 CMS
E.R. Squibb & Sons, L.L.C. $1,656.0003/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727981155 CMS
Alnylam Pharmaceuticals Inc. $56.4503/02/2020 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750758649 CMS
Hikma Pharmaceuticals USA $16.8802/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 729269395 CMS
AstraZeneca Pharmaceuticals LP $24.0202/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735895337 CMS
AstraZeneca Pharmaceuticals LP $50.4002/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736289281 CMS
Amarin Pharma Inc. $13.5001/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739839789 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $10.9901/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720919109 CMS
Novartis Pharmaceuticals Corporation $13.9601/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725995789 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,516.90 64
PY2020 $2,823.11 39
PY2021 $2,590.74 45
PY2022 $737.64 35
PY2023 $454.03 20
PY2024 $2,529.63 39
PY2025 $681.28 22

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $262,318.22 41
PY2024 Principal investigator $226,779.68 27
PY2023 Principal investigator $241,422.11 79
PY2022 Principal investigator $283,192.02 266
PY2021 Principal investigator $197,651.91 425
PY2020 Principal investigator $248,697.42 325
PY2019 Recipient $12,988.10 1
PY2019 Principal investigator $359,002.06 260

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

425 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $1,830.78 12/31/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
AMETHYST Congestive Heart Failure CHF Heart Failure Therapy Area Cardiovascular, Renal and Metabolism No dispute reported 06/30/2026 826475375
Principal investigator 1 Merck Sharp & Dohme Corporation $12,096.04 12/31/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
Double-Blind, Randomized, Placebo-Controlled Phase 2b, Multi-center Study to Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of a 2-Dose and a 3-Dose Regimen of V160 Cytomegalovirus CMV Vaccine in Healthy Seronegative Women, 16 to 35 Years of Age No dispute reported 06/30/2026 848762035
Principal investigator 1 Novo Nordisk AS $70.00 12/31/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 833635467
Principal investigator 1 Novo Nordisk AS $25.06 12/30/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811851245
Principal investigator 1 Novo Nordisk AS $709.31 12/23/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814225
Principal investigator 1 Novo Nordisk AS $1,322.10 12/23/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811876773
Principal investigator 1 ModernaTX, Inc. $5,000.00 12/22/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 860942857
Principal investigator 1 Novo Nordisk AS $5,493.06 12/22/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251609
Principal investigator 1 Novartis Pharmaceuticals Corporation $4,000.00 12/20/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL, ASSESSING THE IMPACT OF INCLISIRAN ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PARTICIPANTS WITH ESTABLISHED CARDIOVASCULAR DISEASE (VICTORION-2 PREVENT) No dispute reported 06/30/2026 800649821
Principal investigator 1 Novo Nordisk AS $25.06 12/17/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708445
Principal investigator 1 Novo Nordisk AS $50.12 12/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708439
Principal investigator 1 Novo Nordisk AS $1,478.53 12/01/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014947
Principal investigator 1 Novo Nordisk AS $70.00 11/30/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 833635465
Principal investigator 1 Novo Nordisk AS $704.25 11/24/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811707411
Principal investigator 1 Novo Nordisk AS $1,706.04 11/24/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858761
Principal investigator 1 Novo Nordisk AS $675.00 10/29/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834855
Principal investigator 1 Novo Nordisk AS $70.00 10/29/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 833635463
Principal investigator 1 Novo Nordisk AS $673.32 10/27/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570929
Principal investigator 1 Novo Nordisk AS $4,458.15 10/27/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811707405
Principal investigator 1 Novo Nordisk AS $2,500.00 10/27/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811788485
Principal investigator 1 AstraZeneca Pharmaceuticals LP $1,293.31 10/20/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
AMETHYST Congestive Heart Failure CHF Heart Failure Therapy Area Cardiovascular, Renal and Metabolism No dispute reported 06/30/2026 826490803
Principal investigator 1 Novo Nordisk AS $4.16 10/15/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811682353
Principal investigator 1 Novo Nordisk AS $7.91 10/15/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811682359
Principal investigator 1 Novo Nordisk AS $11.20 10/15/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811878463
Principal investigator 1 Novo Nordisk AS $25.06 10/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811876779
Principal investigator 1 Novo Nordisk AS $25.06 10/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811876777
Principal investigator 1 Novo Nordisk AS $70.00 09/30/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811876771
Principal investigator 1 Novo Nordisk AS $2,586.67 09/29/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811571081
Principal investigator 1 Novo Nordisk AS $2,398.68 09/27/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811876781
Principal investigator 1 Novo Nordisk AS $4,990.14 09/24/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547277
Principal investigator 1 Novo Nordisk AS $14.95 09/10/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811682347
Principal investigator 1 Novo Nordisk AS $350.00 09/10/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811788481
Principal investigator 1 Novo Nordisk AS $9.99 09/10/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811788483
Principal investigator 1 Novo Nordisk AS $1.00 09/10/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811896031
Principal investigator 1 Novo Nordisk AS $70.00 08/31/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811438319
Principal investigator 1 Novo Nordisk AS $1,958.58 08/30/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547267
Principal investigator 1 Novo Nordisk AS $2,205.85 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814381
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811682307
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811682313
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811682319
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811682325
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811682331
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811682335
Principal investigator 1 Novo Nordisk AS $650.00 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811682341
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811788467
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811788469
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811788471
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811788473
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811788475
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811788477
Principal investigator 1 Novo Nordisk AS $4.99 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811788479
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811788487
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811788489
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811788491
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811878451
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811878453
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811878455
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811878457
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811878459
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811878461
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811895969
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811895971
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811895973
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811895975
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811896015
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811896017
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811896019
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811896021
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811896023
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811896025
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811896027
Principal investigator 1 Novo Nordisk AS $4.99 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811896029
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811896033
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811896035
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811896037
Principal investigator 1 Novo Nordisk AS $2.65 08/25/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX6018-4758 No dispute reported 06/30/2026 811896039
Principal investigator 1 Novo Nordisk AS $23.06 08/20/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814371
Principal investigator 1 Novo Nordisk AS $23.06 08/10/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015185
Principal investigator 1 Novo Nordisk AS $70.00 07/30/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811876769
Principal investigator 1 Novo Nordisk AS $23.06 07/29/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014831
Principal investigator 1 Novo Nordisk AS $23.06 07/28/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708075
Principal investigator 1 Novo Nordisk AS $1,924.02 07/28/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858759
Principal investigator 1 Novo Nordisk AS $1,063.96 07/26/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811571071
Principal investigator 1 Novo Nordisk AS $2,500.00 07/26/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811851241
Principal investigator 1 Novo Nordisk AS $23.06 07/09/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708071
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814123
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814133
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814139
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814149
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814205
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814215
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814321
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814327
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814335
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814345
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814355
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814365
Principal investigator 1 Novo Nordisk AS $32.70 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014779
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014793
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014803
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014817
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014910
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014921
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014933
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015147
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015161
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015171
Principal investigator 1 Novo Nordisk AS $32.70 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570599
Principal investigator 1 Novo Nordisk AS $32.70 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570609
Principal investigator 1 Novo Nordisk AS $32.70 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570793
Principal investigator 1 Novo Nordisk AS $32.70 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570803
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570813
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570823
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570832
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570839
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570849
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570909
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570919
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811571023
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811571033
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811571043
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811571051
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811571061
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708029
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708035
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708041
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708047
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708053
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708059
Principal investigator 1 Novo Nordisk AS $1.90 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708065
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708317
Principal investigator 1 Novo Nordisk AS $19.96 07/02/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708323
Principal investigator 1 Novo Nordisk AS $70.00 06/30/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811438301
Principal investigator 1 Novo Nordisk AS $1,180.12 06/28/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814437
Principal investigator 1 Novo Nordisk AS $4,302.18 06/28/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811252121
Principal investigator 1 Novo Nordisk AS $23.06 06/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570589
Principal investigator 1 Novo Nordisk AS $46.12 06/15/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570579
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251561
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251569
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251579
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251589
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251599
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251625
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251635
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251645
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251655
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811252007
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811252017
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811252027
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811252105
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811252111
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547037
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547045
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547055
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547131
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547141
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547151
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547161
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547171
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547181
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547191
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547201
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547247
Principal investigator 1 Novo Nordisk AS $32.67 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547257
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834811
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834813
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834815
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834817
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834819
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834821
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834827
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834829
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834831
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834833
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834835
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834837
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834839
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834841
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834849
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834851
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858691
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858693
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858695
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858697
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858699
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858701
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858703
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858705
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858707
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858709
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858721
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858723
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858725
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858727
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858729
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858731
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858733
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858735
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858737
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858739
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858741
Principal investigator 1 Novo Nordisk AS $28.45 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858743
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858755
Principal investigator 1 Novo Nordisk AS $13.25 06/14/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858757
Principal investigator 1 Novo Nordisk AS $70.00 05/31/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811876767
Principal investigator 1 Novo Nordisk AS $3,493.26 05/28/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834857
Principal investigator 1 Novo Nordisk AS $1,740.94 05/26/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814417
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814113
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814195
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014716
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014727
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014739
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014751
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014765
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015079
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015093
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015107
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015121
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015133
Principal investigator 1 Novo Nordisk AS $9.98 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570899
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708011
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708017
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708023
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708111
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708301
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708307
Principal investigator 1 Novo Nordisk AS $90.00 05/18/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708311
Principal investigator 1 Novo Nordisk AS $75.00 05/05/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811438291
Principal investigator 1 Novo Nordisk AS $25.00 05/05/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811438309
Principal investigator 1 Novo Nordisk AS $75.00 05/05/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811438329
Principal investigator 1 Novo Nordisk AS $20.25 05/05/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811438339
Principal investigator 1 Novo Nordisk AS $90.00 05/05/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811438349
Principal investigator 1 Novo Nordisk AS $9.75 05/05/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811438357
Principal investigator 1 Novo Nordisk AS $54.00 05/05/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811438543
Principal investigator 1 Novo Nordisk AS $75.00 05/05/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811450097
Principal investigator 1 Novo Nordisk AS $19.17 05/05/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811707381
Principal investigator 1 Novo Nordisk AS $7.95 05/05/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811707387
Principal investigator 1 Novo Nordisk AS $13.50 05/05/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811707393
Principal investigator 1 Novo Nordisk AS $13.50 05/05/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811851243
Principal investigator 1 Novo Nordisk AS $6.26 05/05/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 811876775
Principal investigator 1 Novo Nordisk AS $2,929.32 04/26/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858771
Principal investigator 1 Novo Nordisk AS $1,949.35 04/23/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814397
Principal investigator 1 Merck Sharp & Dohme Corporation $1,637.98 03/31/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability, Efficacy, and Immunogenicity of V591 MV SARS-CoV-2, Live, Recombinant in Healthy Individuals 16 Years of Age or Older No dispute reported 06/30/2026 848761341
Principal investigator 1 Amgen Inc. $275.00 03/28/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9i (cvMOBIUS) No dispute reported 06/30/2026 830981233
Principal investigator 1 Amgen Inc. $275.00 03/28/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
GALACTIC - HF No dispute reported 06/30/2026 830982313
Principal investigator 1 Novo Nordisk AS $23.06 03/26/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570889
Principal investigator 1 Novo Nordisk AS $3,336.20 03/24/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810821039
Principal investigator 1 Novo Nordisk AS $250.00 03/24/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858767
Principal investigator 1 Novo Nordisk AS $8,054.10 03/24/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858769
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814021
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814029
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814039
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814049
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814059
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814067
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814077
Principal investigator 1 Novo Nordisk AS $15.15 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814087
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814095
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814103
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814159
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814169
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814179
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814189
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814245
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814255
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814265
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814275
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814283
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814293
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814301
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814311
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014597
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014611
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014623
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014635
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014649
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014663
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014675
Principal investigator 1 Novo Nordisk AS $39.95 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014689
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014703
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014843
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014857
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014869
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014883
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014897
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014989
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015001
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015013
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015025
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015039
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015053
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811015066
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570493
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570503
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570511
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570519
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570529
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570539
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570549
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570559
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570569
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570859
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570869
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570879
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570949
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570959
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570969
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570979
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570989
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570997
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811571005
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811571015
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811589725
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811707535
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811707541
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811707547
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811707553
Principal investigator 1 Novo Nordisk AS $9.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811707559
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811707565
Principal investigator 1 Novo Nordisk AS $180.00 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811707571
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811707577
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708005
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708081
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708087
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708093
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708099
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708105
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708225
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708231
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708235
Principal investigator 1 Novo Nordisk AS $7.50 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708241
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708247
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708253
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708259
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708265
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708271
Principal investigator 1 Novo Nordisk AS $10.20 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708277
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708283
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708289
Principal investigator 1 Novo Nordisk AS $19.96 03/12/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811708295
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251301
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251311
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251493
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251503
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251513
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251523
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251533
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251543
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251551
Principal investigator 1 Novo Nordisk AS $15.80 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811251615
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811252037
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811252045
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811252055
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811252065
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811252075
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811252085
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811252095
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811258037
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811546967
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811546977
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811546987
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811546997
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547007
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547017
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547027
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547065
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547075
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547085
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547095
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547103
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547111
Principal investigator 1 Novo Nordisk AS $25.96 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547121
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547211
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547219
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547227
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811547237
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834801
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834803
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834805
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834807
Principal investigator 1 Novo Nordisk AS $54.45 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834809
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834823
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834825
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834843
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834845
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834847
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811835477
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858673
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858675
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858677
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858679
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858681
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858683
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858685
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858687
Principal investigator 1 Novo Nordisk AS $55.54 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858689
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858711
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858713
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858715
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858717
Principal investigator 1 Novo Nordisk AS $13.50 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858719
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858745
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858747
Principal investigator 1 Novo Nordisk AS $10.60 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858749
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858751
Principal investigator 1 Novo Nordisk AS $22.76 03/08/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858753
Principal investigator 1 Novo Nordisk AS $250.00 02/26/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811571089
Principal investigator 1 Novo Nordisk AS $2,384.17 02/24/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570463
Principal investigator 1 Novo Nordisk AS $3,201.66 02/22/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858765
Principal investigator 1 Novo Nordisk AS $23.06 02/19/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014975
Principal investigator 1 Novo Nordisk AS $23.06 02/09/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814235
Principal investigator 1 Novo Nordisk AS $60.00 02/03/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 810814013
Principal investigator 1 Novo Nordisk AS $5.10 02/03/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014585
Principal investigator 1 Novo Nordisk AS $36.00 02/03/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811014961
Principal investigator 1 Novo Nordisk AS $25.98 02/03/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570473
Principal investigator 1 Novo Nordisk AS $9.00 02/03/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570483
Principal investigator 1 Novo Nordisk AS $9.00 02/03/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811570939
Principal investigator 1 Novo Nordisk AS $6.50 02/03/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 811707529
Principal investigator 1 SANOFI US SERVICES INC. $25,655.35 02/02/2021 Non-covered Recipient Entity
York Clinical Research LLC
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk No dispute reported 06/30/2026 838663107
Principal investigator 1 Amgen Inc. $1,325.00 01/29/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
(GOULD): a Registry of High Cardiovascular Risk Subjects in the United States No dispute reported 06/30/2026 830982781
Principal investigator 1 Novo Nordisk AS $3,160.08 01/28/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811834799
Principal investigator 1 Novo Nordisk AS $400.00 01/28/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811858763
Principal investigator 1 Amgen Inc. $3,630.00 01/20/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
(GOULD): a Registry of High Cardiovascular Risk Subjects in the United States No dispute reported 06/30/2026 830982779
Principal investigator 1 Novartis Pharmaceuticals Corporation $11,583.00 01/19/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
MULTI-CENTER CROSS-SECTIONAL EPIDEMIOLOGICAL STUDY TO CHARACTERIZE THE PREVALENCE AND DISTRIBUTION OF LIPOPROTEIN(A) LEVELS AMONG PATIENTS WITH ESTABLISHED CARDIOVASCULAR DISEASE No dispute reported 06/30/2026 800649633
Principal investigator 1 Novartis Pharmaceuticals Corporation $44,011.62 01/15/2021 Non-covered Recipient Entity
YORK CLINICAL RESEARCH
A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL ASSESSING THE IMPACT OF LIPOPROTEIN (A) LOWERING WITH TQJ230 ON MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH ESTABLISHED CARDIOVASCULAR DISEASE No dispute reported 06/30/2026 800649631